Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Feb 16, 2012

29777_dirs_2012-02-16_bbd4698e-cb7a-49b0-8ab8-481901f3cc4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-02-14

Reporting Person: Murray Corlis D (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-14 Common shares without par value M 2371 $53.625 Acquired 39754 Direct
2012-02-14 Common shares without par value S 100 $55.0309 Disposed 39654 Direct
2012-02-14 Common shares without par value S 381 $55.0310 Disposed 39273 Direct
2012-02-14 Common shares without par value S 100 $55.0301 Disposed 39173 Direct
2012-02-14 Common shares without par value S 1790 $55.0300 Disposed 37383 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-14 Option (right to buy) $53.625 M 2371 Disposed 2012-02-14 Common shares (2371) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 6945 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 14, 2012.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.